Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indices put up a strong show...
Fri, 13 Feb Closing

The Indian markets opened the day's proceedings on a firm note. While the early hours saw the indices trade within a range, buying momentum intensified thereafter across index heavyweights. This buoyancy continued in the final trading hour as well and the indices closed well above the dotted line. The BSE-Sensex closed higher by about 290 points, while the NSE-Nifty ended higher by about 94 points. Gains were largely seen in banking, auto and FMCG stocks. The BSE Mid Cap index and the BSE Small Cap index also did well and notched gains of about 0.7% and 0.4% respectively.

Asian stocks ended the day on a mixed note, while most stocks in Europe were trading firm. The rupee was trading at Rs 62.19 to the dollar at the time of writing.

Pharma stocks closed firm today with the key gainers being Biocon, Cadila Healthcare and Glenmark Pharma. Ipca<> announced results for the third quarter and nine months ended December 2014. The company's revenues grew by 6.5% YoY largely due to the 14% YoY growth in domestic sales. The performance of exports continued to remain muted as sales were down 6% YoY. This was attributed to challenges in scaling up supplies, lower tender uptake and change in the business model to make it more front end. Operating profits, however, grew at a faster pace of 18.5% YoY led by continuous focus on cost management. Net profits, in the meanwhile, grew by 15% YoY during the quarter. For the nine month period, the company had made 33 product filings in Europe and 10 filings for North America. The stock closed firm today.

Auto ancillary stocks closed mixed today. While Amtek Auto, Amara Raja Batteries and Bharat Forge found favour, Bosch Ltd and Exide Industries closed in the red. Bosch Ltd announced results for the fourth quarter ended December 2014. The company reported a 14% YoY increase in revenues for the quarter led by the gradual ramp up in auto volumes leading to better performance of its diesel and gasoline business divisions. Operating margins, however, were under pressure as they declined by 0.6% to 9.3%. As a result of this, operating profits grew at a slower pace of 7% YoY. Net profits declined by 20% YoY during the quarter largely on account of higher tax expenses and an extraordinary expense to the tune of Rs 280 m. The latter represented one time charges in retirement benefits consequent to wage settlement during the period. Excluding the impact of extraordinary items, growth in net profits was flat.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indices put up a strong show...". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.